Skip to content

Reliability of the Melbourne Assessment

Reliability of the Melbourne Assessment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02595411
Enrollment
30
Registered
2015-11-03
Start date
2015-07-31
Completion date
2016-12-31
Last updated
2017-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Nervous System Diseases, Cerebral Palsy, Meningomyelocele, Stroke, Traumatic Brain Injury

Keywords

Children, Rehabilitation, Upper Limb, Assessments, Outcome Measures

Brief summary

The aim of the study is to investigate the reliability of the Melbourne Assessment.

Detailed description

Children with central motor disorders will be tested twice within one week with the Melbourne Assessment. The assessments will be video scored. At a later time point, different raters will rate the same video for inter-rater reliability, the same rater will score the same video for intra-rater reliability, and the same rater will score the repeated assessment videos for test-retest reliability.

Interventions

None listed

Sponsors

University Children's Hospital, Zurich
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
30 Months to 20 Years
Healthy volunteers
No

Inclusion criteria

* central motor disorders * ambulant or stationary patients of the Rehabilitation Center Affoltern am Albis * ability to understand test instructions * ability to sit upright for 25 minutes * minimal activity in the assessed upper limb

Exclusion criteria

* severe visual and/or auditory problems * acute lesion in the to assessed upper limb * lack of compliance

Design outcomes

Primary

MeasureTime frameDescription
Melbourne Assessment 22 assessments within 1 weekAssessment to measure unilateral upper limb function

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026